ACADIA Pharmaceuticals
NasdaqGS:ACAD Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 64 Fair Values set on narratives written by author
WA
Consensus Narrative from 20 Analysts
New CEO Will Lead Global Expansion Of CNS And Rare Disease Therapies
Key Takeaways Appointing a new CEO with drug launch expertise may enhance strategic execution and sales growth, strengthening revenue and net margins. Expanding drug pipeline and international reach can significantly boost revenue, supported by strategic branding efforts and market introductions.
View narrativeUS$24.95
FV
20.0% undervalued intrinsic discount10.32%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
23 days ago author updated this narrative